InvestorsHub Logo
Followers 83
Posts 6546
Boards Moderated 0
Alias Born 05/10/2006

Re: None

Thursday, 05/30/2013 2:41:17 PM

Thursday, May 30, 2013 2:41:17 PM

Post# of 447
VERY NICE!!! SOON COMING CHINA EFFECT... LOAD UP... I MAY BE THE ONLY HOLDER IN THE WORLD.... WANT TO SHOOT AT THE MOON BUY WHAT YOU CAN AFFORD TO LOSE... Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.